Compounds > 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
Page last updated: 2024-09-04

1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and daunorubicin

1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione has been researched along with daunorubicin in 1 studies

Compound Research Comparison

Studies
(1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione)		Trials
(1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione)		Recent Studies (post-2010)
(1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione)		Studies
(daunorubicin)		Trials
(daunorubicin)		Recent Studies (post-2010) (daunorubicin)
6038,2398861,310

Protein Interaction Comparison

ProteinTaxonomy1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione (IC50)daunorubicin (IC50)
72 kDa type IV collagenaseHomo sapiens (human)1.9
Multidrug resistance-associated protein 1 Homo sapiens (human)8
Histone deacetylase 1Homo sapiens (human)0.047
Histone deacetylase 8Homo sapiens (human)0.22
Histone deacetylase 6Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kharasch, ED; Novak, RF1

Other Studies

1 other study(ies) available for 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and daunorubicin

ArticleYear
Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 226, Issue:2

    Topics: Animals; Anthraquinones; Antineoplastic Agents; Daunorubicin; Doxorubicin; Lipid Peroxides; Liver; Male; Mitoxantrone; Myocardium; Rabbits; Rats; Rats, Inbred Strains

1983